KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
KIORA PHARMACEUTICALS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.38−0.02 (-0.83%)
Close on Oct 19, 2026
- Market cap
- $14.70M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Kiora Pharmaceuticals has not reported a dividend
No dividend per share appears in Kiora Pharmaceuticals's annual filings since fiscal 2013.